Autres langues Calian Group Ltd.

Actions

CGY

CA12989J1084

Marché Fermé - Toronto S.E. Autres places de cotation 22:00:00 24/04/2024			Varia. 5j.	Varia. 1 janv.
55,25 ^CAD	+0,45 %		-0,43 %	-3,56 %

27/03	Calian annonce la nomination de Valérie Travain-Milone au poste de présidente des technologies avancées	CI
21/03	Calian Group Ltd. fournira une technologie de simulation des interférences du spectre à l'Agence spatiale canadienne	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Calian Group Brief: Appointing Valerie Travain-Milone as President, Advanced Technologies (AT)	27/03
Calian Announces the Appointment of New President of Advanced Technologies	27/03
Calian Announces the Appointment of Valérie Travain-Milone as President, Advanced Technologies	27/03
Correction: -- Calian Group Brief: Says to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency	21/03
Calian Group Says to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency	21/03
Calian Group and MDA Brief: Says to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency	21/03
Calian to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency	21/03
Calian Group Ltd. to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency	21/03
Calian : Named to CRN’s 2024 Tech Elite 250 List	19/03
Calian : to Support NATO SHAPE in Development and Execution of Military Training Program	14/03
North American Morning Briefing : Stock Futures Rise Ahead of Powell's Testimony	06/03
Calian Group and MDA Brief: Calian Says "Strengthens Nuclear Capability" with Acquisition of MDA Ltd. Nuclear Assets	05/03
Calian Strengthens Nuclear Capability with Acquisition of MDA Ltd. Nuclear Assets	05/03
Calian Group Ltd. acquired Assets And Nuclear Services of MDA Ltd.	05/03
Calian Group Says Won Contract to Support Clinical Trial for ZYUS Life Sciences' Lead Drug Product Candidate	20/02
Calian Group Brief: Says Won Contract to Support Clinical Trial for ZYUS Life Sciences' Lead Drug Product Candidate	20/02
Calian Wins Contract to Support Clinical Trial for ZYUS Life Sciences’ Lead Drug Product Candidate	20/02
Calian Group Ltd. Wins Contract to Support Clinical Trial for Zyus Life Sciences? Lead Drug Product Candidate	20/02
Calian Reports on the Election of Directors Voting Results	20/02
Calian Group Fiscal Q1 Profit Rises 21% on Revenue Gains	14/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Calian Group Ltd.

Actions

CGY

CA12989J1084

Autres langues

Filtres